from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3864/espE

LFCtreatmentdescriptionclass of inhibitor

0.656

Amikacinug/mL Amikacintranslation

0.578

Cap5-10ug/mL Capreomycintranslation

0.769

Rox10-50 ug/mL Roxithromycintranslation

1.101

SM2-5 ug/mL Streptomycintranslation

0.939

Tet5-10 ug/mL Tetracyclinetranslation

-0.683

Rif0.2-5ug/mL Rifampicintranscription

-0.303

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.268

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.284

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.447

CPZ10-50 ug/mL Chlorpromazinerespiration

0.032

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.363

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.328

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.611

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.227

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.342

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.988

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.086

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.698

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.010

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.194

KCN5-20 ug/mL Potassium cyaniderespiration

0.192

NaN30.2-2 mM Sodium aziderespiration

0.485

Nigericin50 uM Nigericinrespiration

0.169

TRC10-150 ug/mL Triclosanrespiration

0.383

TRZ10-25 ug/mL Thioridazinerespiration

4.361

Valinomycin0.5-10 uM Valinomycinrespiration

0.129

ZnSO42 mM ZnSO4respiration

0.432

menadione6-10 ug/mL Menadionerespiration

0.047

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.517

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.109

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.337

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.131

NRP_1Non-replicating persistence stage 1dosRassociated

0.180

Amp0.2mg/mL AmpicillincellWall

-0.144

Cephalexin20-100 ug/mL CephalexincellWall

0.026

Cerulenin0.32-5 ug/mL CerulenincellWall

0.287

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.812

EMB10-20 ug/mL EthambutolcellWall

-0.165

Eta12-40 ug/mL EthionamidecellWall

-0.277

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.246

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.327

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.784

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.745

BZA0.12 mg/mL BenzamidearomaticAmides

-0.016

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.386

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.698

H2O24 mM hydrogen peroxideDNAdamaging

0.222

Levo10 ug/mL LevofloxacinDNAdamaging

-0.385

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.691

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.144

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.594

UVUV-irradiationDNAdamaging

-1.302

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.442

Antimycin12.5-50 ug/mL Antimycin A?

-0.124

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.033

PA_110-50 ug/mL Antitubercular compound PA-1?

0.402

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.284

PA8240.2-2 ug/mL PA-824?

-0.446

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.815

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.446

Verapamil50 uM Verapamil?

0.267

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.609

methoxatin10-20 ug/mL Methoxatin?